Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01817452 |
|---|---|
| Brief Title: | A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol (ADAPT) |
| First Submitted : | March 18, 2013 |
| First Submitted that Met QC Criteria : | March 22, 2013 |
| First Posted : | March 25, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 23, 2023 |
| Last Update Posted : | March 24, 2023 |